XECCAPSMA Trademark

Trademark Overview


On Thursday, October 23, 2025, a trademark application was filed for XECCAPSMA with the United States Patent and Trademark Office. The USPTO has given the XECCAPSMA trademark a serial number of 79442196. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 14, 2026. This trademark is owned by Cellbion Co., Ltd.. The XECCAPSMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of cancer; radiopharmaceuticals for treatment of cancer; radioactive substances for medical purposes; sealed radioactive substances for medical purposes; radioactive contrast substances for medical use; radiological contrast substances for medical purposes; radiopharmaceutical preparations for diagnostic purposes; radioisotope markers for therapeutic or diagnostic use; radiopharmaceuticals for treatment of prostate cancer; radiopharmaceuticals for cancer treatment; radioactive pharmaceuticals for treatment of cancer; radioactive therapeutic pharmaceuticals for treatment of cancer; pharmaceutical preparations for treatment of metastatic cancer; nuclear medicine therapeutic preparations for treatment of cancer; pharmaceutical preparations for cancer treatment; contrast agents for nuclear medicine imaging and therapy; prostate cancer-targeting agents, namely, Radiopharmaceutical imaging agents or tracer agents for diagnosis and monitoring cancer; ...
xeccapsma

General Information


Serial Number79442196
Word MarkXECCAPSMA
Filing DateThursday, October 23, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, July 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Translation of Words in MarkThe wording XECCAPSMA has no meaning in a foreign language.
Goods and ServicesPharmaceutical preparations for treatment of cancer; radiopharmaceuticals for treatment of cancer; radioactive substances for medical purposes; sealed radioactive substances for medical purposes; radioactive contrast substances for medical use; radiological contrast substances for medical purposes; radiopharmaceutical preparations for diagnostic purposes; radioisotope markers for therapeutic or diagnostic use; radiopharmaceuticals for treatment of prostate cancer; radiopharmaceuticals for cancer treatment; radioactive pharmaceuticals for treatment of cancer; radioactive therapeutic pharmaceuticals for treatment of cancer; pharmaceutical preparations for treatment of metastatic cancer; nuclear medicine therapeutic preparations for treatment of cancer; pharmaceutical preparations for cancer treatment; contrast agents for nuclear medicine imaging and therapy; prostate cancer-targeting agents, namely, Radiopharmaceutical imaging agents or tracer agents for diagnosis and monitoring cancer; peptide-based radiolabeled agents for therapeutic or diagnostic medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 29, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellbion Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Thursday, January 29, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, February 1, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, February 1, 2026APPLICATION FILING RECEIPT MAILED
Tuesday, March 10, 2026ASSIGNED TO EXAMINER
Thursday, March 12, 2026NON-FINAL ACTION WRITTEN
Friday, March 13, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 24, 2026REFUSAL PROCESSED BY MPU
Friday, April 24, 2026NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 18, 2026REFUSAL PROCESSED BY IB
Wednesday, July 8, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 8, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 8, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 8, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 14, 2026APPROVED FOR PUB - PRINCIPAL REGISTER